Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 42, Pages 15564
Publisher
Baishideng Publishing Group Inc.
Online
2014-11-14
DOI
10.3748/wjg.v20.i42.15564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
- (2013) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma
- (2013) Daniel E. Abbott et al. ANNALS OF SURGICAL ONCOLOGY
- Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
- (2013) R Alvarez et al. BRITISH JOURNAL OF CANCER
- A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- (2013) Edward J. Kim et al. CANCER
- Stromal expression of SPARC in pancreatic adenocarcinoma
- (2013) Cindy Neuzillet et al. CANCER AND METASTASIS REVIEWS
- Prospects of miRNA-Based Therapy for Pancreatic Cancer
- (2013) Priya Pai et al. CURRENT DRUG TARGETS
- Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma
- (2013) Deyali Chatterjee et al. HISTOPATHOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
- (2013) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival
- (2013) Ching-Wei D. Tzeng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification
- (2013) Ching-Wei D. Tzeng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients
- (2013) Mitsuro Kanda et al. SURGERY TODAY
- Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
- (2013) Umashankar K. Ballehaninna et al. TUMOR BIOLOGY
- Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
- (2013) Sung W. Cho et al. HPB
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study
- (2013) Marius Distler et al. International Journal of Surgery
- Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
- (2012) J. M. Pipas et al. ANNALS OF ONCOLOGY
- Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
- (2012) Falk Roeder et al. BMC CANCER
- Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer
- (2012) Makoto Shinoto et al. CANCER
- Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer
- (2012) J.A. van der Zee et al. EJSO
- Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer
- (2012) Stephen P. Malkoski et al. FEBS LETTERS
- HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
- (2012) K Kim et al. ONCOGENE
- Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
- (2012) Chandra Bartholomeusz et al. Journal of Cancer
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
- (2011) Stefan Heinrich et al. BMC CANCER
- A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
- (2011) J L Bryant et al. BRITISH JOURNAL OF CANCER
- Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer
- (2011) Richard Kim et al. CANCER
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- The Smad family and its role in pancreatic cancer
- (2011) P Singh et al. INDIAN JOURNAL OF CANCER
- A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma
- (2011) P Singh et al. INDIAN JOURNAL OF CANCER
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma
- (2011) Hidenori Takahashi et al. SURGERY
- Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?
- (2011) Jeffrey A. Glant et al. SURGERY
- Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
- (2011) Jeremy L Davis et al. Trials
- Molecular biology of pancreatic cancer
- (2011) Miroslav Zavoral WORLD JOURNAL OF GASTROENTEROLOGY
- NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer
- (2011) Klaus Sahora et al. WORLD JOURNAL OF SURGERY
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
- (2010) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
- (2010) Andrew H. Ko et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response
- (2010) O. Turrini et al. EJSO
- Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma
- (2010) Jerome Landry et al. JOURNAL OF SURGICAL ONCOLOGY
- Neoadjuvant therapy for pancreatic cancer: A current review
- (2010) Daniel E. Abbott et al. JOURNAL OF SURGICAL ONCOLOGY
- The role of radiotherapy in multimodal treatment of pancreatic carcinoma
- (2010) Thomas B Brunner et al. Radiation Oncology
- NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
- (2010) Klaus Sahora et al. SURGERY
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function
- (2009) Peng Wang et al. CARCINOGENESIS
- Significant Associations of Mismatch Repair Gene Polymorphisms With Clinical Outcome of Pancreatic Cancer
- (2009) Xiaoqun Dong et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate Synthase and Dihydropyrimidine Dehydrogenase Are Upregulated in Pancreatic and Biliary Tract Cancers
- (2009) Mitsugi Shimoda et al. PATHOBIOLOGY
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
- (2009) Roland Andersson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- A Compendium of Potential Biomarkers of Pancreatic Cancer
- (2009) H. C. Harsha et al. PLOS MEDICINE
- Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
- (2008) Pehr A. Lind et al. ACTA ONCOLOGICA
- Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma
- (2008) Romuald Le Scodan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity
- (2008) Stefan Heinrich et al. ANNALS OF SURGERY
- High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1
- (2008) Hidekazu Kuramochi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Stefan Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Therapy for Pancreatic Cancer
- (2008) Andrew M. Lowy JOURNAL OF GASTROINTESTINAL SURGERY
- Effect of Neoadjuvant Therapy on Local Recurrence after Resection of Pancreatic Adenocarcinoma
- (2008) Sarah E. Greer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search